Loading company…
Riskpilot
← Back to search
Sign in
Get full access
PROKARIMI AS
AS
Bankrupt
Org 932746026
Ulvenveien 80B, 0581 Oslo
Retail sale of medical and orthopaedic goods · NACE 4774
Est. 2024
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 123K
EBITDA margin
-2162.7%
Equity ratio
-60.7%
Financial strength
Net profit 2024
NOK -2,7M
1 employees
EBITDA — year on year
NOK millions
0M
-1M
-2M
-3M
-4M
-3M
2024
Key figures
Annual report 2024
Revenue
NOK 123K
—
EBITDA
NOK -2,7M
—
Net profit
NOK -2,7M
—
Total assets
NOK 712K
—
Equity
NOK -432K
—
Employees
1
—
Company information
Legal name
PROKARIMI AS
Org number
932746026
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
2. januar 2024
Share capital
NOK 819 048
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Salg av mikrobiotatesting med verdiøkende tjenster/produkter til konsumentmarkedet og nærliggende relevante/tilgrensende aktiviteter.
Contact
Address
Ulvenveien 80B, 0581 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of medical and orthopaedic goods
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
NOK millions
0M
-1M
-2M
-3M
-3M
-3M
2024
Income statement
NOK thousands
Item
2024
Revenue
123
Staff expenses
−431
EBITDA
−2 666
Depreciation & amort.
−0
EBIT
−2 666
Net financials
−1
Profit before tax
−2 667
Tax
−0
Net profit
−2 667
Balance sheet
NOK thousands
Item
2024
Total assets
712
Equity
−432
Long-term debt
0
Short-term debt
1 144
Total debt
1 144
Financial ratios
5-year trend
EBITDA margin
-2162.7%
This company
15.8%
Market median
-13788% vs market
2024
2024
Equity ratio
-60.7%
This company
38.2%
Market median
-259% vs market
2024
2024
Return on equity
-266680100.0%
This company
18.4%
Market median
-1449348470% vs market
2024
2024
Net profit margin
-2163.2%
This company
8.1%
Market median
-26806% vs market
2024
2024
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
2024
2024
Debt / equity
2.65×
This company
0.62×
Market median
-327% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
AG
Atle Gram
Board of Directors
2025
—
—
FM
Fredrik Medby Hagen
Board of Directors
2024
—
—
SS
Sondre Skaug Bjørnebekk
Chairman
2024
—
—
RH
Ronny Hermansen
Board of Directors
2024
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Awesome Holding As
Company
34.0%
34.0%
2024
Innovation Consulting As
Company
34.0%
34.0%
2024
Genetic Analysis As
Company
24.0%
24.0%
2024
Knut Espen Bryhn
Individual
6.0%
6.0%
2024
Mabeni As
Company
2.0%
2.0%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of PROKARIMI AS also hold positions in
0
other companies.
Person
Role here
Other companies
Atle Gram
Board of Directors
0 companies
Fredrik Medby Hagen
Board of Directors
0 companies
Sondre Skaug Bjørnebekk
Chairman
0 companies
Ronny Hermansen
Board of Directors
0 companies